Safety and Efficacy of a Single Dose of Anti-D (WinRho(®)) in Severe Thrombocytopenia Secondary to Dengue Virus Infection

OBJECTIVE: To evaluate the efficacy of a single intravenous (IV) dose of anti-D in severe thrombocytopenia (<20,000) due to dengue virus (DEV) infection. MATERIALS AND METHODS: An open label, investigator-initiated, randomized interventional study was conducted that included thirty dengue patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Pannu, Ashok Kumar, Bhalla, Ashish, Singhal, Mayank, Suri, Vikas, Shafiq, Nusrat, Varma, Subhash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330058/
https://www.ncbi.nlm.nih.gov/pubmed/28250602
http://dx.doi.org/10.4103/ijccm.IJCCM_386_16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330058/
https://www.ncbi.nlm.nih.gov/pubmed/28250602
http://dx.doi.org/10.4103/ijccm.IJCCM_386_16

Ejemplares similares